The effect of lovastatin and thioridazine on the degradation of cocaine in human serum in vitro

Therapeutic Drug Monitoring

Volumn 27, Issue 2, 2005, Pages 168-170

  Bailey, David N ^a,b   Briggs, John R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

Cocaine degradation; Human serum; Lovastatin; Pseudocholinesterase; Thioridazine

Indexed keywords

CHOLINESTERASE; COCAINE; ECGONINE METHYL ESTER; MEVINOLIN; THIORIDAZINE;

ARTICLE; CATABOLISM; COCAINE DEPENDENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG EFFECT; DRUG MONITORING; ENZYME ACTIVITY; ENZYME INHIBITION; HALF LIFE TIME; HUMAN; IN VITRO STUDY; INCUBATION TIME; PRIORITY JOURNAL; SERUM;

COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; HUMANS; LOVASTATIN; MALE; PSEUDOCHOLINESTERASE; SERUM; TEMPERATURE; THIORIDAZINE; TIME FACTORS;

EID: 16244372099     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000151187.68593.12     Document Type: Article

References (14)

1. Darvesh S, Martin E, Walsh R, et al. Differential effects of lipid-lowering agents on human cholinesterases. Clin Biochem. 2004;37:42-49.
2. Nasello AG, Gidali D, Felicio LF. Comparative study of the anticholinesterase activity of several antipsychotic agents. Pharmacol Biochem Behav. 2003;75:895-901.
3. Stewart DJ, Inaba T, Tang BK, et al. Hydrolysis of cocaine in human plasma by cholinesterase. Life Sci. 1977;20:1557-1564.
4. Stewart DJ, Inaba T, Lucassen M, et al. Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases. Clin Pharmacol Ther. 1979;25:464-468.
5. Hoffman RS, Henry GC, Wax PM, et al. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice. J Pharmacol Exp Ther. 1992;263:698-702.
6. Om A, Ellahham S, Ornato JP, et al. Medical complications of cocaine: possible relationship to low plasma cholinesterase enzyme. Am Heart J. 1993;125:1114-1117.
7. Bailey DN. Comprehensive review of cocaethylene and cocaine concentrations in patients. Am J Clin Pathol. 1996;106:701-704.
8. Ye LY, Firby PS, Moore MJ. Determination of lovastatin in human plasma using reverse-phase high-performance liquid chromatography with UV detection. Ther Drug Monit. 2000;22:737-741.
9. Baselt RC. Disposition of Toxic Drugs and Chemicals in Man, 6th ed. Foster City, CA: Biomedical Publications, 2002:1020-1024.
10. ARUP User's Guide. Pseudocholinesterase, Total. Salt Lake City: ARUP Laboratories, 2004.
11. Jatlow P, Nadim H. Determination of cocaine concentrations in plasma by high-performance liquid chromatography. Clin Chem. 1990;36:1436-1439.
12. Ellman GL, Courtney KD, Andres V, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88-95.
13. Brown SE, Nejtek VA, Perantie DC, et al. Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation. J Clin Psychopharmacol. 2003;23:384-388.
14. LeDuc PA, Mittleman G. Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence. Psychopharmacology. 1995;121:407-427.